Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Llor, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Llor, X.
Clinical Cancer Research Vol. 11, 7304-7310, October 15, 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Differential Features of Colorectal Cancers Fulfilling Amsterdam Criteria without Involvement of the Mutator Pathway

Xavier Llor1, Elisenda Pons1, Rosa M. Xicola1, Antoni Castells2, Cristina Alenda4, Virgínia Piñol2, Montserrat Andreu3, Sergi Castellví-Bel2, Artemio Payá4, Rodrigo Jover5, Xavier Bessa3, Anna Girós1, Anna Roca1, Miquel A. Gassull1 for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association

Authors' Affiliations: 1 Gastroenterology Department, Germans Trias i Pujol Hospital, Universitat Autonòma de Barcelona; 2 Department of Gastroenterology, Institut de Malalties Digestives, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona; 3 Department of Gastroenterology, Hospital del Mar, Barcelona, Spain; and Departments of 4 Pathology and 5 Gastroenterology, Hospital General Universitario de Alicante, Alicante, Spain

Requests for reprints: Xavier Llor, Gastroenterology Department, Germans Trias i Pujol Hospital, Carretera del Canyet s/n 08916 Badalona, Barcelona, Spain. Phone: 011-34-93-465-1200, ext. 3716; Fax: 011-34-93-497-8843; E-mail: xllor{at}comb.es.

Purpose: Hereditary nonpolyposis colorectal cancer (HNPCC) is the commonest form of inherited colorectal cancer. Whereas it has been known that mismatch repair gene mutations are the underlying cause of HNPCC, an undetermined number of patients do not have these alterations. The main objectives of this study were to assess the relevance of clinically defined HNPCC patients without characteristic mutator pathway alterations and to identify their specific features.

Experimental Design: This was a prospective, population-based, cohort that included 1,309 newly diagnosed colorectal cancer patients. Demographic, clinical, pathologic data and tumor DNA from probands as well as a detailed family history were collected. Microsatellite analysis and MLH1, MSH2, and MSH6 immunohistochemistry were done. Germ line MLH1 and MSH2 mutational analysis was done in all patients with evidence of MMR alterations.

Results: Twenty-five patients (1.9%) fulfilled Amsterdam criteria of HNPCC but 15 (60%) of them did not have microsatellite instability and showed normal expression of MMR proteins. These patients presented mostly left-sided tumors without lymphocytic infiltrate; they were older, had fewer family members affected with colorectal or endometrial cancers, and more often fulfilled Amsterdam II criteria than HNPCC patients with microsatellite instability. Like unstable HNPCC patients, this group without mutator pathway alterations had a significant percentage of synchronous and metachronous adenomatous polyps and cancers.

Conclusions: We define an important group of HNPCC families with specific features, no evidence of mismatch repair deficiency, and an autosomal dominant trait with a lesser penetrance than HNPCC with deficiency.




This article has been cited by other articles:


Home page
GutHome page
J. Young, M. Jenkins, S. Parry, B. Young, D. Nancarrow, D. English, G. Giles, and J. Jass
Serrated pathway colorectal cancer in the population: genetic consideration
Gut, October 1, 2007; 56(10): 1453 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Sanchez-de-Abajo, M. de la Hoya, M. van Puijenbroek, A. Tosar, J.A. Lopez-Asenjo, E. Diaz-Rubio, H. Morreau, and T. Caldes
Molecular Analysis of Colorectal Cancer Tumors from Patients with Mismatch Repair Proficient Hereditary Nonpolyposis Colorectal Cancer Suggests Novel Carcinogenic Pathways
Clin. Cancer Res., October 1, 2007; 13(19): 5729 - 5735.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. T. Lynch, C. R. Boland, M. A. Rodriguez-Bigas, C. Amos, J. F. Lynch, and P. M. Lynch
Who Should Be Sent for Genetic Testing in Hereditary Colorectal Cancer Syndromes?
J. Clin. Oncol., August 10, 2007; 25(23): 3534 - 3542.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
L. Valle, J. Perea, P. Carbonell, V. Fernandez, A. M. Dotor, J. Benitez, and M. Urioste
Clinicopathologic and Pedigree Differences in Amsterdam I-Positive Hereditary Nonpolyposis Colorectal Cancer Families According to Tumor Microsatellite Instability Status
J. Clin. Oncol., March 1, 2007; 25(7): 781 - 786.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. M. Xicola, X. Llor, E. Pons, A. Castells, C. Alenda, V. Pinol, M. Andreu, S. Castellvi-Bel, A. Paya, R. Jover, et al.
Performance of Different Microsatellite Marker Panels for Detection of Mismatch Repair-Deficient Colorectal Tumors
J Natl Cancer Inst, February 7, 2007; 99(3): 244 - 252.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Young and J. R. Jass
The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1778 - 1784.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.